Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.contraception.2005.09.005
DC FieldValue
dc.titleActinomyces in cervical smears of women using the intrauterine device in Singapore
dc.contributor.authorKalaichelvan, V.
dc.contributor.authorMaw, A.A.
dc.contributor.authorSingh, K.
dc.date.accessioned2011-09-15T08:21:59Z
dc.date.available2011-09-15T08:21:59Z
dc.date.issued2006
dc.identifier.citationKalaichelvan, V., Maw, A.A., Singh, K. (2006). Actinomyces in cervical smears of women using the intrauterine device in Singapore. Contraception 73 (4) : 352-355. ScholarBank@NUS Repository. https://doi.org/10.1016/j.contraception.2005.09.005
dc.identifier.issn00107824
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/26008
dc.description.abstractObjectives: Reproductive tract actinomyces have been associated with the use of intrauterine contraceptive device (IUCD). Thus, there is a need to evaluate the prevalence of colonization with Actinomyces israelii in a cohort of Singaporean women using an IUCD. Second, the occurrence of actinomycosis in colonized women and the clinical need to remove the IUCD and/or possibly the need to treat asymptomatic carriers with antibiotics were evaluated. Methods: The study population consisted of 1108 IUCD users attending the Fertility Control Clinic, National University Hospital, Singapore. Results: In our study, the prevalence of actinomyces-positive cervical smears among IUCD users was 13.7%; the incidence of actinomyces-positive smears was similar with Copper T (34.2%), Multiload (32.9%) and Nova T (32.9%) IUCDs. We found no association with the duration of use of IUCD and actinomyces infection. In our study, 150 out of 152 (98.7%) IUCD users with actinomyces-positive smears were asymptomatic, and only 2 out of 152 (1.3%) who had actinomyces-positive cervical smears developed pelvic inflammatory disease at 6 months. Conclusions: Our study suggests that removal of the IUCD in asymptomatic women with actinomyces-positive cervical smear is not necessary. Moreover, we suggest that asymptomatic carriers of actinomyces do not require preemptive antibiotic treatment. © 2006 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.contraception.2005.09.005
dc.sourceScopus
dc.subjectActinomyces
dc.subjectCervical smears
dc.subjectIntrauterine device use
dc.typeArticle
dc.contributor.departmentOBSTETRICS & GYNAECOLOGY
dc.description.doi10.1016/j.contraception.2005.09.005
dc.description.sourcetitleContraception
dc.description.volume73
dc.description.issue4
dc.description.page352-355
dc.identifier.isiut000236377500007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

17
checked on Apr 13, 2021

WEB OF SCIENCETM
Citations

12
checked on Apr 13, 2021

Page view(s)

239
checked on Apr 14, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.